Machine learning expert: Health information revolution is underway

Machine learning expert: Health information revolution is underway

In medicine, notes Tingting Zhao, Ph.D., there’s no such matter as much too a great deal facts. “When it arrives to building the most effective selections for their patients, health professionals often want to know a lot more,” she suggests. An assistant professor of Info Techniques and Analytics and a college fellow with Bryant’s Centre of Wellbeing and Behavioral Sciences, Zhao is an rising leader in healthcare informatics, a industry that presents new insights into keeping us much healthier and much better informed.

Zhao, an achieved researcher, studies a vary of subjects at the intersection of facts, technological innovation, and health-related expertise. That fusion, she suggests, is an critical and remarkable frontier with limitless likely. “By combining all a few of them, we can make better choices in conditions of public plan, illness command, and ailment prevention,” claims Zhao, who will be educating in Bryant’s new Healthcare Informatics graduate method this tumble.

As technologies evolves, it generates more data than at any time before. Some estimates suggest that the health care industry generates as substantially as 30 per cent of the world’s data, a number that could increase to 36 {08cd930984ace14b54ef017cfb82c397b10f0f7d5e03e6413ad93bb8e636217f} by 2025, in accordance to RBC Capital Markets. Healthcare informatics, which integrates health care sciences, pc science, information and facts science, and cognitive science, can help practitioners figure out new approaches to use data to boost shipping of care, make improvements to patient schooling, and inform general public wellbeing coverage. 

It is now additional critical than ever that experts have the skills and understanding to understand, use, and innovate with data, says Zhao, pointing to the rise of precision medication, an rising method for illness therapy and avoidance that requires into account individual variability in genes, atmosphere, and life style. It’s a aggressive and enjoyable location, she says — one fueled by a need to generate new strategies to take care of sufferers. “We can create much more economical units to not just file that data but to use it to make knowledgeable selections as nicely.”

“The total entire world is knowing we should really put much more assets into producing new technologies to assist us provide improved health care and far better fully grasp what makes us unwell.”

Particular wellbeing products these kinds of as Apple Watches and Fitbits are other examples of the well being data revolution, states Zhao. “We are connecting with and producing new items of element know-how and new methods that we can use as analytical applications to examine client behaviors,” she suggests.

The COVID-19 pandemic, Zhao claims, greatly lifted recognition of the value of the area and led to a huge inflow of funding for info-linked health care projects on the countrywide level, taking it from roughly $23 billion to virtually $96 billion. “The total globe is acknowledging we should really put more means into acquiring new systems to assistance us provide much better healthcare and greater understand what makes us unwell,” she states.

An skilled in device learning, a department of artificial intelligence and personal computer science that focuses on the use of information and algorithms to imitate the way people discover, Zhao designed her passion for combining info science with healthcare as a doctoral college student, when she found the thrill of knowing that a thing she labored on could one working day assist actual everyday living individuals. “It was thrilling to know this was the potential,” she suggests.

Zhao has considering the fact that contributed to a wide variety of projects, such as a Countrywide Institutes of Health and fitness-funded collaboration with Harvard Clinical School and Northeastern Team to acquire algorithms that can discover Chronic Obstructive Pulmonary Disease (COPD) and make predictions regarding its progress. Her most new study examine, which included acquiring and honing algorithms to identify which genes reply to distinct perturbation stressors, which can provide a greater comprehending of the fundamental mechanisms of ailment and advance the identification of new drug targets, was posted in the prestigious journal Briefings in Bioinformatics.

“This is an possibility to do meaningful function that benefits the entire local community.”

Pupils in the university’s Health care Informatics graduate program, Zhao suggests, will acquire exposure to analysis done by their professors, together with opportunities to join them in scholarly work. “When college students arrive listed here, they can learn what definitely goes on in the subject,” claims Zhao, who cites doing work with junior partners on investigate assignments as one of her preferred pieces of getting a professor.

The method aligns very well with Bryant’s other new graduate plans in Data Science and Business Analytics, notes Zhao, who is training programs in both of those. This presents alternatives for suggestions to cross-pollinate and lead to new insights and improvements. The health care informatics field, especially, is excellent for curious persons who want to discover — and to locate strategies to use their skills and their instruction to support other individuals. 

“This is an chance to do meaningful operate that advantages the overall group,” claims Zhao.

Artificial Intelligence in Health Care: Benefits and Challenges of Machine Learning Technologies for Medical Diagnostics

Artificial Intelligence in Health Care: Benefits and Challenges of Machine Learning Technologies for Medical Diagnostics

What GAO Found

Several machine learning (ML) technologies are available in the U.S. to assist with the diagnostic process. The resulting benefits include earlier detection of diseases; more consistent analysis of medical data; and increased access to care, particularly for underserved populations. GAO identified a variety of ML-based technologies for five selected diseases — certain cancers, diabetic retinopathy, Alzheimer’s disease, heart disease, and COVID-19 —with most technologies relying on data from imaging such as x-rays or magnetic resonance imaging (MRI). However, these ML technologies have generally not been widely adopted.

Academic, government, and private sector researchers are working to expand the capabilities of ML-based medical diagnostic technologies. In addition, GAO identified three broader emerging approaches—autonomous, adaptive, and consumer-oriented ML-diagnostics—that can be applied to diagnose a variety of diseases. These advances could enhance medical professionals’ capabilities and improve patient treatments but also have certain limitations. For example, adaptive technologies may improve accuracy by incorporating additional data to update themselves, but automatic incorporation of low-quality data may lead to inconsistent or poorer algorithmic performance.

Spectrum of adaptive algorithms

We identified several challenges affecting the development and adoption of ML in medical diagnostics:

  • Demonstrating real-world performance across diverse clinical settings and in rigorous studies.
  • Meeting clinical needs, such as developing technologies that integrate into clinical workflows.
  • Addressing regulatory gaps, such as providing clear guidance for the development of adaptive algorithms.

These challenges affect various stakeholders including technology developers, medical providers, and patients, and may slow the development and adoption of these technologies.

GAO developed three policy options that could help address these challenges or enhance the benefits of ML diagnostic technologies. These policy options identify possible actions by policymakers, which include Congress, federal agencies, state and local governments, academic and research institutions, and industry. See below for a summary of the policy options and relevant opportunities and considerations.

Policy Options to Help Address Challenges or Enhance Benefits of ML Diagnostic Technologies

  Opportunities Considerations

Evaluation (report
page 28)

Policymakers could create incentives, guidance, or policies to encourage or require the evaluation of ML diagnostic technologies across a range of deployment conditions and demographics representative of the intended use.

This policy option could help address the challenge of demonstrating real world performance.

  • Stakeholders could better understand the performance of these technologies across diverse conditions and help to identify biases, limitations, and opportunities for improvement.
  • Could inform providers’ adoption decisions, potentially leading to increased adoption by enhancing trust.
  • Information from evaluations can help inform the decisions of policymakers, such as decisions about regulatory requirements.
  • May be time-intensive, which could delay the movement of these technologies into the marketplace, potentially affecting patients and professionals who could benefit from these technologies.
  • More rigorous evaluation will likely lead to extra costs, such as direct costs for funding the studies. Developers may not be incentivized to conduct these evaluations if it could show their products in a negative light, so policymakers could consider whether evaluations should be conducted or reviewed by independent parties, according to industry officials.

Data Access (report
page 29)

Policymakers could develop or expand access to high-quality medical data to develop and test ML medical diagnostic technologies. Examples include standards for collecting and sharing data, creating data commons, or using incentives to encourage data sharing.

This policy option could help address the challenge of demonstrating real world performance.

  • Developing or expanding access to high-quality datasets could help facilitate training and testing ML technologies across diverse and representative conditions. This could improve the technologies’ performance and generalizability, help developers understand their performance and areas for improvement, and help to build trust and adoption in these technologies.
  • Expanding access could enable developers to save time in the development process, which could shorten the time it takes for these technologies to be available for adoption.
  • Entities that own data may be reluctant to share them for a number of reasons. For example, these entities may consider their data valuable or proprietary. Some entities may also be concerned about the privacy of their patients and the intended use and security of their data.
  • Data sharing mechanisms may be of limited use to researchers and developers depending on the quality and interoperability of these data, and curating and storing data could be expensive and may require public and private resources.

Collaboration (report
page 30)

Policymakers could promote collaboration among developers, providers, and regulators in the development and adoption of ML diagnostic technologies. For example, policymakers could convene multidisciplinary experts together in the design and development of these technologies through workshops and conferences.

This policy option could help address the challenges of meeting medical needs and addressing regulatory gaps.

  • Collaboration between ML developers and providers could help ensure that the technologies address clinical needs. For example, collaboration between developers and medical professionals could help developers create ML technologies that integrate into medical professionals’ workflows, and minimize time, effort, and disruption.
  • Collaboration among developers and medical providers could help in the creation and access of ML ready data, according to NIH officials.
  • As previously reported, providers may not have time to both collaborate with developers and treat patients; however, organizations can provide protected time for employees to engage in innovation activities such as collaboration. 
  • If developers only collaborate with providers in specific settings, their technologies may not be usable across a range of conditions and settings, such as across different patient types or technology systems.

Source: GAO. | GAO-22-104629

Why GAO Did This Study

Diagnostic errors affect more than 12 million Americans each year, with aggregate costs likely in excess of $100 billion, according to a report by the Society to Improve Diagnosis in Medicine. ML, a subfield of artificial intelligence, has emerged as a powerful tool for solving complex problems in diverse domains, including medical diagnostics. However, challenges to the development and use of machine learning technologies in medical diagnostics raise technological, economic, and regulatory questions.

GAO was asked to conduct a technology assessment on the current and emerging uses of machine learning in medical diagnostics, as well as the challenges and policy implications of these technologies. This report discusses (1) currently available ML medical diagnostic technologies for five selected diseases, (2) emerging ML medical diagnostic technologies, (3) challenges affecting the development and adoption of ML technologies for medical diagnosis, and (4) policy options to help address these challenges.

GAO assessed available and emerging ML technologies; interviewed stakeholders from government, industry, and academia; convened a meeting of experts in collaboration with the National Academy of Medicine; and reviewed reports and scientific literature. GAO is identifying policy options in this report.

For more information, contact Karen L. Howard at (202) 512-6888 or howardk@gao.gov.